Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Medicine, Internal medicine, Hypertrophic cardiomyopathy, Cardiology, Subclinical infection, and Valsartan.
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
Abstract 4147845: Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Trial Cardiac Magnetic Resonance Substudy
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling
Baseline Characteristics of the VANISH Cohort
Fulminant Myocarditis with Combination Immune Checkpoint Blockade